Table of contents

1. Some aspects of the treatment, detection, and costs of focusing on pulmonary arterial hypertension

   Manuel Benavides Luna, MD., Adriana Torres Navas, MD., Carlos Arias Barrera, MD. (Author)

   Article visits 427 | PDF visits 681

   PDF (Spanish) FLIP

2. Resistant and extrapulmonary tuberculosis: two challenges for today’s clinician

   Juan Carlos Rojas Puentes, MD. (Author)

   Article visits 428 | PDF visits 413

   PDF (Spanish) FLIP

1. Search for patients with pulmonary hypertension at the Hospital Universitario San Ignacio

   Darío Londoño, MD., MSc., Claudio Villaquirán MD., MSc., Elena Mora Figueroa, MD. (Author)

   Article visits 844 | PDF visits 133

   PDF (Spanish) FLIP

2. Identification of direct and indirect costs in pulmonary hypertension in Colombia.

   Darío Londoño, Claudio Villaquirán, Rubén Dueñas, Efraín Gómez, Paola Coral (Author)

   Article visits 710 | PDF visits 679

   PDF (Spanish) FLIP

1. Pulmonary Vasodilators. Part 2

   Clara Patricia García, MD. (Author)

   Article visits 613 | PDF visits 1289

   PDF (Spanish) FLIP

1. Endobronchial metastases of bronchogenic carcinoma

   Alejandra Alejandra Cañas, MD. (Author)

   Article visits 350 | PDF visits 214

   PDF (Spanish) FLIP

1. Tuberculous pericarditis: case report and literature review

   María Isabel Arbeláez, Jairo Andrés Fonseca, Erika Paola Vergara, Paulina Ojeda, Francisco González, Oscar Alberto Sáenz, Juan Carlos Martínez, Diego Pinto, Diego Díaz, Paola Bonilla (Author)

   Article visits 4574 | PDF visits 4895

   PDF (Spanish) FLIP

2. Drug resistant tuberculosis

   Luis Eduardo Ramírez Bejarano, Julia Edith Chamorro Ortega (Author)

   Article visits 1259 | PDF visits 3109

   PDF (Spanish) FLIP

1. Assessment of real-time polymerase chain reaction (RT-PCR), interferon gamma, adenosine deaminase, and immunoglobulin A for diagnosing pleural tuberculosis

   María Fernanda Buitrago Rodríguez, MD., Olga Milena García, MD. (Author)

   Article visits 371 | PDF visits 515

   PDF (Spanish) FLIP

2. Hipertensión arterial pulmonar. El uso de macitentán disminuye la mortalidad y morbilidad de los pacientes con hipertensión arterial pulmonar

   Edward Cáceres Méndez, Claudio Villaquirán (Author)

   Article visits 423 | PDF visits 542

   PDF (Spanish) FLIP

1. Emphysema

   Ana Cristina Manzano D., MD., Olga Milena García, MD., Carlos Celis Preciado, MD. (Author)

   Article visits 917 | PDF visits 21337

   PDF (Spanish) FLIP